Seven polymorphic sites in the β-globin gene cluster were analyzed on a sample of 96 chromosomes of Venezuelan sickle cell patients from the State of Aragua. The Benin haplotype was predominant with a frequency of 0.479, followed by the Bantu haplotype (0.406); a minority of cases with other haplotypes was also identified: atypical Bantu A2 (0.042), Senegal (0.031), atypical Bantu A7 (0.021) and Saudi Arabia/Indian (0.021) haplotypes; however, the Cameroon haplotype was not identified in this study. Our results are in agreement with the historical records that establish Sudanese and Bantu origins for the African slaves brought into Venezuela.
Introduction
Sickle cell disease (SCD) exhibits a wide spectrum of clinical behavior: everything from a mild condition to an incapacitating illness; its hematological characteristics, as well as its clinical severity, are influenced by variations in fetal hemoglobin (HbF) levels (Falusi and Olatungi, 1994; Steinberg, 1996) , the simultaneous presence of α-thalassemia (Figueiredo et al., 1996; Mukherjee et al., 1997) glucose-6-phosphate dehydrogenase deficiency (Bouanga et al., 1998) and the β-globin cluster linked haplotypes (Powars and Hiti, 1993; Powars et al., 1994; Steinberg, 1996) . The β S gene is in linkage disequilibrium with five main different haplotypes of the β gene cluster, which were named according to the geographical areas where they are most prevalent: Benin, Cameroon, Central African Republic (CAR or Bantu), Senegal and Saudi Arabia/Indian (SAI) (Pagnier et al., 1984; Kulozik et al., 1986; Lapouméroulie et al., 1992) . Sickle cell disease was introduced into the American continent mainly by the massive trade of African slaves which occurred between the sixteenth and nineteenth centuries, and is the most common hereditary disorder in the Americas. Sickle cell epidemiological studies carried out in Venezuela demonstrated a variable frequency, ranging from zero in the Venezuelan Indians up to 5 percent in the Mestizo and Afro-American populations; in some regions such as the North Central Coastal Region the frequency has risen to as much as 12% (Arends, 1971; Arends et al., 1982) . In order to provide the required information for further analysis of the heterogeneity of the hematological parameters and clinical manifestations of SCD in Venezuela, the DNA β-globin gene cluster haplotypes were analyzed in 48 Venezuelan sickle cell patients from the State of Aragua. The results were compared with those found in other studies with Venezuelan patients (Arends et al., 2000) , Guadeloupe Island and Iberoamerican populations of Cuba (Muniz et al., 1995) , Colombia (Cuellar-Ambrosi et al., 2000) and Brazil Figueiredo et al., 1994; Gonçalves et al., 1994; Pante de Sousa et al., 1998 , 1999 .
Subjects and Methods
The patient sample was composed of 48 non-related HbS homozygotes, from the State of Aragua, which is in the North Central Coastal Region of Venezuela, at about 9°23' to 10°33' N. and 66°33' to 67°53' W. The population of this State is the result of an intense process of admixture among Caucasians, Amerindians, and Afro-Americans and its total population size, according to the 1990 census (OCEI, 1990) represents 6.2% of the Venezuelan population. These patients were attended at the Hematological Service at the Maracay Central Hospital in the State of Aragua. There were 23 males and 25 females, with a mean age of 21 ± 3.3 years.
Venous blood samples were collected using EDTA as an anticoagulant, and the hematological parameters were determined by standard laboratory procedures. The buffy coat was used for the preparation of nuclear DNA according to previously described methods (Kirby, 1992) . Diagnosis of SCD was based on the Bsu36I digestion of a PCR amplified 536 bp., verifying whether the β-globin DNA segment contained the β S mutation, as reported previously (Martínez et al., 1998) . Haplotypes were determined by the analysis of the following polymorphic restriction sites in the β-globin gene cluster: 1) Hinc II 5' of ε; 2) Xmn I 5' of Gγ; 3) Hind III in the IVSII of Gγ; 4) Hind III in the IVSII of Aγ; 5) Hinc II in the Ψβ; 6) Hinc II 3' of Ψβ; and 7) Hinf I 5' β. Segments containing each of these sites were amplified by PCR and subsequently digested with the appropriate enzyme. The oligonucleotide primers used for the analysis of sites 2 to 7 were described by Sutton et al. (1989) and site 1 was analyzed using a primer reported by Guerreiro et al. (1992) .
Results
The β-globin cluster haplotypes identified in the Venezuelan patients are presented in Table I . Benin is the most frequent with a frequency of 0.479, followed by Bantu (0.406), Senegal (0.031), and Saudi Arabia/Indian (0.021). The Bantu A2 and Bantu A7 atypical haplotypes described by Srinivas et al. (1988) were observed with a frequency of 0.042 and 0.021, respectively. No Cameroon haplotypes were identified in this study. Fourteen of the 48 SCD patients were homozygous for the Benin haplotype (29.2%), 9 were Bantu homozygotes (18.7%) and all the others were heterozygotes (52.1%). Table II shows the β S typical haplotype frequency distribution among the Venezuelan patients studied in this work, compared with those from several Iberoamerican populations and Caribbean Islands.
Discussion
The data reported in this study indicated that the Benin (47.9%) and Bantu (40.6%) haplotypes were the most prevalent, Senegal was present in 3.1% of the patients, a value similar to that found in the western region of Colombia (4.3%) and the Belém population of Brazil (3.4%). The frequencies of the two atypical haplotypes, Bantu A2 (4.2%) and Bantu A7 (2.1%), are some of the highest reported in American populations. This observation can be interpreted as resulting from of recombinatorial events involving the Bantu typical haplotype and the 5' regions from various haplotypes present in normal individuals as described by Srinivas et al. (1988) . In an admixed population such as the Venezuelan, there are more probabilities of observing these events.
Fifty-two percent of the SCD patients studied presented heterozygous haplotypes, as was expected due to the 22 Moreno et al. admixture process which occurs in our population; in a study carried out on African SCD patients, the vast majority of haplotypes were found in homozygosity (Sow et al., 1995) . Our results differed significantly from those reported by Arends et al. (2000) in another study performed on sickle cell Venezuelan patients from all over the country (χ 2 = 14.62; d.f. = 4; p < 0.01). This may be due to different patient ascertainment and/or a diverse historical origin of the African-derived patients from Aragua. On the other hand, our results are in agreement with the haplotype distribution found in patients from Cuba (χ 2 = 6.60; d.f. = 3; p > 0.05); while significant differences exist with the Colombian data (χ 2 = 11.23; d.f. = 4; p < 0.025). A highly significant difference was observed when the Venezuelan patients were compared with those from Guadeloupe (χ 2 = 42.63 d.f. = 2; p < 0.001), and those from Brazil (χ 2 = 20.03; d.f.= 3; p < 0.001). It is probable that all these differences reflect the origin of the forced migration of African slaves to the American continent, although, as was indicated for the two Venezuelan samples, patient ascertainment should also be considered.
African slavery was instituted in Venezuela to meet the growing labor demands of an emerging agricultural economy; historically it is reported that the African slaves brought to Venezuela were from the Sudan and Bantu regions (Acosta Saignes, 1984) , although some slaves came to Venezuela from the others colonies, especially the Antilles; in consequence, the predominance of the Benin and Bantu haplotypes is in accordance with these historical records.
